NLRP3 and myelodysplastic syndrome: This is evidenced by the finding that epigenetic dysregulation is associated with activation of NOD-like receptor protein 3 (NLRP3) inflammasomes, followed by increasing levels of damage-associated molecular patterns (DAMPs) in MDS.